-+ 0.00%
-+ 0.00%
-+ 0.00%

Serina Therapeutics Divests Its UniverXome Subsidiary; Transaction Eliminates $11.2M In Debt

Benzinga·01/15/2025 21:06:55
Listen to the news

The transaction was finalized on December 23, 2024 and eliminated $11.2 million in associated subsidiary-level debt, positioning Serina with a debt-free balance sheet heading into 2025.